ATE216237T1 - Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade - Google Patents

Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade

Info

Publication number
ATE216237T1
ATE216237T1 AT94919912T AT94919912T ATE216237T1 AT E216237 T1 ATE216237 T1 AT E216237T1 AT 94919912 T AT94919912 T AT 94919912T AT 94919912 T AT94919912 T AT 94919912T AT E216237 T1 ATE216237 T1 AT E216237T1
Authority
AT
Austria
Prior art keywords
ropivacaine
pct
analgesic
produce
minimal motor
Prior art date
Application number
AT94919912T
Other languages
German (de)
English (en)
Inventor
Arne Torsten Eek
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE216237(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE216237T1 publication Critical patent/ATE216237T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Air Conditioning Control Device (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Particle Accelerators (AREA)
  • Medicinal Preparation (AREA)
AT94919912T 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade ATE216237T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
PCT/SE1994/000496 WO1995000148A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Publications (1)

Publication Number Publication Date
ATE216237T1 true ATE216237T1 (de) 2002-05-15

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94919912T ATE216237T1 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade

Country Status (32)

Country Link
US (2) US5670524A (enExample)
EP (1) EP0706395B1 (enExample)
JP (1) JP3725541B2 (enExample)
CN (1) CN1074918C (enExample)
AT (1) ATE216237T1 (enExample)
BR (1) BR9406865A (enExample)
CA (1) CA2165446C (enExample)
CZ (1) CZ283300B6 (enExample)
DE (2) DE706395T1 (enExample)
DK (1) DK0706395T3 (enExample)
EE (1) EE03205B1 (enExample)
ES (1) ES2099048T3 (enExample)
FI (1) FI956269L (enExample)
GR (1) GR970300013T1 (enExample)
HU (1) HU218949B (enExample)
IL (1) IL110006A (enExample)
IS (1) IS4174A (enExample)
LT (1) LT3449B (enExample)
LV (1) LV12918B (enExample)
MY (1) MY119360A (enExample)
NO (1) NO955313D0 (enExample)
NZ (1) NZ268110A (enExample)
PH (1) PH31258A (enExample)
PL (1) PL175518B1 (enExample)
PT (1) PT706395E (enExample)
RU (1) RU2152215C1 (enExample)
SA (1) SA94150010B1 (enExample)
SE (1) SE9302218D0 (enExample)
SG (1) SG49078A1 (enExample)
SK (1) SK280111B6 (enExample)
TW (1) TW285640B (enExample)
WO (1) WO1995000148A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009061497A1 (en) 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
AU2013257727B2 (en) * 2012-05-10 2016-04-28 Cellixbio Private Limited Compositions and methods for the treatment of local pain
CN104427977B (zh) * 2012-05-10 2018-02-02 佩因拉佛姆有限公司 局部麻醉剂的储库制剂及其制备方法
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
NZ710740A (en) 2013-02-28 2020-06-26 Dermira Inc Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) * 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
JPH09500620A (ja) 1997-01-21
CN1074918C (zh) 2001-11-21
EE03205B1 (et) 1999-08-16
GR970300013T1 (en) 1997-05-31
WO1995000148A1 (en) 1995-01-05
CA2165446A1 (en) 1995-01-05
EP0706395A1 (en) 1996-04-17
ES2099048T1 (es) 1997-05-16
NZ268110A (en) 1999-06-29
DE69430427T2 (de) 2002-11-14
DE706395T1 (de) 1997-09-04
PT706395E (pt) 2002-09-30
HU9503692D0 (en) 1996-02-28
FI956269A7 (fi) 1995-12-27
HU218949B (hu) 2001-01-29
LV12918B (en) 2003-03-20
US5834489A (en) 1998-11-10
NO955313L (no) 1995-12-27
CZ283300B6 (cs) 1998-02-18
FI956269A0 (fi) 1995-12-27
HK1010344A1 (en) 1999-06-17
SK280111B6 (sk) 1999-08-06
PH31258A (en) 1998-06-18
CZ336495A3 (en) 1996-06-12
ES2099048T3 (es) 2002-11-16
IL110006A0 (en) 1994-11-11
BR9406865A (pt) 1996-03-26
IL110006A (en) 1999-01-26
LT3449B (en) 1995-10-25
CA2165446C (en) 2005-07-05
SA94150010B1 (ar) 2006-04-04
RU2152215C1 (ru) 2000-07-10
AU692161B2 (en) 1998-06-04
US5670524A (en) 1997-09-23
SK164695A3 (en) 1996-07-03
TW285640B (enExample) 1996-09-11
LTIP1958A (en) 1995-01-31
IS4174A (is) 1994-12-29
MY119360A (en) 2005-05-31
CN1126435A (zh) 1996-07-10
PL312198A1 (en) 1996-04-01
EP0706395B1 (en) 2002-04-17
AU7086694A (en) 1995-01-17
DE69430427D1 (de) 2002-05-23
PL175518B1 (pl) 1999-01-29
NO955313D0 (no) 1995-12-27
JP3725541B2 (ja) 2005-12-14
FI956269L (fi) 1995-12-27
SG49078A1 (en) 1998-05-18
DK0706395T3 (da) 2002-07-22
HUT75115A (en) 1997-04-28
SE9302218D0 (sv) 1993-06-28

Similar Documents

Publication Publication Date Title
NO960067L (no) Nytt farmasöytisk preparat
MY115662A (en) Novel compounds with analgesic effect
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
ATE174508T1 (de) Verwendung von bis (amidinobenzidazolen) zur herstellung eines medikamentes für die hemmung der retroviral integrase
ATE220904T1 (de) 2-phenyl-3-azoylbenzothiophene zur erhöhung der thrombomodulin expression
NO982778L (no) Morfinderivater med smertestillende virkning
DE69612510D1 (de) Verwendung von 1-(2-naphtylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode
DE69430427D1 (de) Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
DE69626301D1 (de) Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen
ATE240101T1 (de) Verwendung von 2-phenyl-3- aroylbenzothiophenderivaten zur herstellung eines medikaments zur knochen- und bruchheilung
DE68910010D1 (de) Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin.
ATE200623T1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der primären endometriumhyperplasie
ATE204872T1 (de) Verfahren zur herstellung von anhydroecgonin- estern
MX9804797A (es) Nuevos compuestos con efecto analgesico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee